RT Journal Article
SR Electronic
T1 Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 546
OP 547
DO 10.2967/jnumed.117.202630
VO 59
IS 3
A1 Elif Hindié
A1 Clément Morgat
A1 Paolo Zanotti-Fregonara
A1 Magalie Haissaguerre
A1 Laurence Bordenave
A1 Antoine Tabarin
YR 2018
UL http://jnm.snmjournals.org/content/59/3/546.abstract
AB